Literature DB >> 30127086

Differential Influence on Regulatory B Cells by TH2 Cytokines Affects Protection in Allergic Airway Disease.

Sophina H Taitano1,2, Luciën E P M van der Vlugt1, Molly M Shea1, Jennifer Yang1, Nicholas W Lukacs2,3, Steven K Lundy4,2.   

Abstract

The role of regulatory B cells (Bregs) in modulating immune responses and maintaining tolerance are well established. However, how cytokines present during immune responses affect Breg growth and function are not as well defined. Previously, our laboratory reported IL-5- and mCD40L-expressing fibroblast (mCD40L-Fb) stimulation induced IL-10 production from murine B cells. The current study investigated the phenotype and functional relevance of IL-10- producing B cells from this culture. We found IL-5/mCD40L-Fb stimulation induced IL-10 production exclusively from CD5+ splenic B cells of naive mice. After stimulation, the resulting IL-10+ B cells displayed markers of multiple reported Breg phenotypes. Interestingly, when investigating effects of IL-4 (a critical TH2 cytokine) on IL-5/mCD40L-Fb-induced IL-10 production, we found IL-4 inhibited IL-10 production in a STAT6-dependent manner. Upon adoptive transfer, CD5+ B cells previously stimulated with IL-5/mCD40L-Fb were able to reduce development of OVA-induced allergic airway disease in mice. Using B cells from IL-10 mutant mice differentiated by IL-5/mCD40L-Fb, we found protection from allergic airway disease development was dependent on the IL-10 production from the transferred B cells. Bregs have been shown to play crucial roles in the immune tolerance network, and understanding stimuli that modulate their growth and function may be key in development of future treatments for diseases of immune dysregulation.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30127086      PMCID: PMC6143409          DOI: 10.4049/jimmunol.1800206

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  64 in total

1.  Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.

Authors:  J Tian; D Zekzer; L Hanssen; Y Lu; A Olcott; D L Kaufman
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

2.  Reconstitution of a functional human type II IL-4/IL-13 receptor in mouse B cells: demonstration of species specificity.

Authors:  R Andrews; L Rosa; M Daines; G Khurana Hershey
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

3.  Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10.

Authors:  Steven K Lundy; Dov L Boros
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection.

Authors:  C A Pennell; T J Mercolino; T A Grdina; L W Arnold; G Haughton; S H Clarke
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

5.  The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model.

Authors:  Tamar Tadmor; Yu Zhang; Hyun-Mi Cho; Eckhard R Podack; Joseph D Rosenblatt
Journal:  Cancer Immunol Immunother       Date:  2011-01-21       Impact factor: 6.968

6.  Deficiency of regulatory B cells increases allergic airway inflammation.

Authors:  S K Lundy; A A Berlin; T F Martens; N W Lukacs
Journal:  Inflamm Res       Date:  2005-12       Impact factor: 4.575

7.  Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model.

Authors:  Sylvie Amu; Sean P Saunders; Mitchell Kronenberg; Niamh E Mangan; Ann Atzberger; Padraic G Fallon
Journal:  J Allergy Clin Immunol       Date:  2010-03-20       Impact factor: 10.793

8.  The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production.

Authors:  Byoung-gon Moon; Satoshi Takaki; Kensuke Miyake; Kiyoshi Takatsu
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

9.  PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding.

Authors:  Xuemei Zhong; Joseph R Tumang; Wenda Gao; Chunyan Bai; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

10.  Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice.

Authors:  C Mohan; L Morel; P Yang; E K Wakeland
Journal:  Arthritis Rheum       Date:  1998-09
View more
  4 in total

1.  CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitus.

Authors:  Andrew D Vonberg; Maria Acevedo-Calado; Aaron R Cox; Susan L Pietropaolo; Roberto Gianani; Steven K Lundy; Massimo Pietropaolo
Journal:  JCI Insight       Date:  2018-12-06

2.  Characterization and Activation of Fas Ligand-Producing Mouse B Cells and Their Killer Exosomes.

Authors:  Steven K Lundy; Sophina H Taitano; Luciën E P M van der Vlugt
Journal:  Methods Mol Biol       Date:  2021

3.  Mechanism(s) of prolonged attenuation of allergic responses after modulation of idiotypic regulatory network.

Authors:  R M Gorczynski; T Maqbool; G Hoffmann
Journal:  Allergy Asthma Clin Immunol       Date:  2019-12-04       Impact factor: 3.406

4.  CircRNA expression profiles and circRNA-miRNA-mRNA crosstalk in allergic rhinitis.

Authors:  Chang-Yu Qiu; Xin-Yan Cui; Mei-Ping Lu; Min Yin; Wan-Yun Xu; Xin-Jie Zhu; Qing Yang; Lei Cheng
Journal:  World Allergy Organ J       Date:  2021-06-18       Impact factor: 4.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.